Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Progress Software Connects Enterprise Knowledge Across Business Systems with New Agentic RAG Capabilities
GlobeNewswire, Inc.
New release extends trusted enterprise AI across delivery, retrieval and content ingestion, enabling organizations to scale AI experiences without rebuilding existing deployments BURLINGTON, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Progress...
Kinetic’s Global Partnerships Accelerate Fiber Expansion, Reduce Costs, Enhance Customer Experience via ‘QuickConnect’ technology
GlobeNewswire, Inc.
LITTLE ROCK, Ark., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Kinetic, the insurgent residential and business fiber internet provider, announced its strategic partnership with STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite...
PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility
GlobeNewswire, Inc.
MONTREAL, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to...
H2C Safety Pipe Expands Its Board with California Energy and Infrastructure Leaders Robert Hertzberg, Marty Adams, and Janice Lin
GlobeNewswire, Inc.
SANTA BARBARA, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- H2C Safety Pipe, Inc. (H2CSP), developer of proprietary technologies for hydrogen transport and storage, announced that Robert M. Hertzberg, Martin L. Adams, and Janice Lin have joined the...
Kabuki Syndrome Foundation Launches Kabuki INSIGHTS to Support Future Treatment Development
EIN Presswire
Research platform designed to help researchers better understand Kabuki syndrome, strengthen clinical trial readiness, and inform future treatment development.
Nxera Announces Successful Resolution of miniG Patent Infringement Action
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited (“Nxera”) has entered into a settlement agreement...
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
GlobeNewswire, Inc.
CEO Discusses How Addition of Accomplished Oncology Drug Developer Strengthens Ernexa Ahead of Clinical Development Following ERNA-101 Data Demonstrating Complete Tumor Clearance and 100% Survival in Combination with anti-PD-1 Discussion...
AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data
GlobeNewswire, Inc.
OCALA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage focused on the Company’s development strategy for Ampligen® (rintatolimod) in metastatic...
What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?
GlobeNewswire, Inc.
Baltimore, MD, Oct. 01, 2026 (GLOBE NEWSWIRE) -- The signs of poor metabolic health can be difficult to analyze without a clinical framework.
Lantronix Secures Blue UAS Companion Computer SOM Listing, Expanding Defense Drone Opportunity
GlobeNewswire, Inc.
IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned compute systems, critical infrastructure and resilient enterprise...
Autonomize Introduces Autonomize Context AI™, the Missing Context Foundation That Makes AI Agents Grounded, Useful, and Scalable for Healthcare Enterprises
GlobeNewswire, Inc.
AUSTIN, Texas, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Autonomize announced the general availability of Autonomize Context AI™, a shared intelligence foundation that transforms fragmented enterprise knowledge into living context that healthcare AI...
Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care
GlobeNewswire, Inc.
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As Canada’s inflammatory bowel disease (IBD) population continues to grow, Crohn’s and Colitis Canada is committed to invest 1.5 million over three years across four research projects aimed at advancing...
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
GlobeNewswire, Inc.
Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a...
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
GlobeNewswire, Inc.
PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX₁₀₀ Last month Validation confirms that the application is complete and EMA initiates formal review of D-PLEX₁₀₀ D-PLEX₁₀₀ NDA concurrently under FDA...
Kleinschmidt Canada Welcomes Regan Willenborg as Project Engineer
EIN Presswire
Project Engineer brings 8 years of experience to support continued growth of Kleinschmidt Canada PETERBOROUGH, ONTARIO, CANADA, October 1, 2026 /EINPresswire.com/ -- Kleinschmidt Canada, an employee-owned consulting firm specializing in...
Applied Materials and Besi Expand Strategic Partnership to Advance Next-Generation Packaging for AI Scaling
GlobeNewswire, Inc.
Besi joins Applied's EPIC Center as an Innovation Partner, extending a collaboration that began in 2020 with the companies' joint Hybrid Bonding Center of Excellence in Singapore Expanded collaboration targets next-generation 3D IC scaling, logic...
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
GlobeNewswire, Inc.
PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where...
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
GlobeNewswire, Inc.
Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores among LX2006-treated participants compared with propensity-matched control cohort from UNIFAI natural history study...
Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting
GlobeNewswire, Inc.
PASADENA, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that its affiliated experts from UCLA Stein Eye Institute will share research findings and clinical...
FingerMotion and BlueFlare Sign Binding Agreement to Acquire 20-Acre Site in Hanna, Alberta, Establishing Hanna Campus #1 for AI Inference Compute
GlobeNewswire, Inc.
Owned land with a pathway to grid and behind-the-meter natural gas power expands FingerMotion's Alberta AI infrastructure footprint WEST PALM BEACH, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- FingerMotion, Inc. (Nasdaq: FNGR) ("FingerMotion" or the...
Sign up for:
Technology News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.